PART I Overview We are a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy. Our growing product portfolio is purposefully designed to leverage the patients natural healing response while minimizing long-term exposure to permanent synthetic materials. We are committed to delivering our advanced technologies with a strong econom...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001104659-26-034507 | EDGAR | 86K words |
| 2025-03-21 | 2024-12-31 | 0001558370-25-003460 | EDGAR | — |
| 2024-03-22 | 2023-12-31 | 0001558370-24-003782 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0001558370-23-004468 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0001558370-22-004151 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001558370-21-003483 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001558370-20-003346 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001104659-25-112476 | EDGAR | 21K words |
| 2025-08-11 | 2025-06-30 | 0001558370-25-011052 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006994 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001558370-24-015050 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001558370-24-012060 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007784 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018822 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014494 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009426 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017464 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013286 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001558370-22-008301 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001104659-26-033839 | EDGAR | 3K words |
| 2026-03-20 | 0001104659-26-032697 | EDGAR | — |
| 2025-11-14 | 0001104659-25-112653 | EDGAR | — |
| 2025-11-13 | 0001104659-25-111285 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105548 | EDGAR | — |
| 2025-10-09 | 0001104659-25-098354 | EDGAR | — |
| 2025-08-11 | 0001104659-25-076153 | EDGAR | — |
| 2025-06-02 | 0001104659-25-055248 | EDGAR | — |
| 2025-05-30 | 0001104659-25-054867 | EDGAR | — |
| 2025-05-08 | 0001104659-25-046124 | EDGAR | — |
129 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001561921 |
| Ticker | TELA |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.telabio.com |
| Listed | 2019-11-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report